Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2023 Nov 21;44(1):24–47. doi: 10.1161/ATVBAHA.123.320138

Table 9:

Population-based studies assessing ABI as a predictor of future cardiovascular events or death published since the ABI Collaboration in 2008115

Study [ref] Country, Year of publication Population (% men, mean age) Follow-up (years) Outcome
(n=)
Measurement Adjusted HR (95% CI)* Ethnicity and/or other comments
MESA159 USA 2019 6669 (49%, 62y) 14.2 CVD
(288)
ABI<0.9 2.15
[1.55,3.44]
Abstract only. Lower ABI of lower leg
NHANES160 USA 2021 7571 (N/A, 60y) 8 CVD
(204)
ABI<0.9 3.92
[1.81–5.28]
Abstract only
ARTPER116 Spain 2018 2716 (43%, 62y) 9 CV events & death (187) ABI<0.9 2.55
[1.53–4.24]
REGICOR161 Spain 2017 5679 (54%, 55.4y) 6.2 CVD
(59)
ABI>1.4 3.1
[1.95–6.48]
REGICOR123 Spain 2015 5248 (45%, 53.7y) 5.9 CV events
(175)
ABI<0.9 3.03
[1.86,4.95]
5248
(45%)
ARIC121 USA 2012 1594 (44%. 53.8y) 10 CV events
(659)
ABI<0.9 1.18
[1.10,1.27]
24% black
Hoorn
162
Holland
2012
624 (49.5%, 64.7y) 17.2 CVD (85) ABI<0.9 2.57
[1.50–4.40]

Similar HR with/without type 2 diabetes
MESA
122
USA
2011
6647 (49%, 62.1y) 5.3 CV events
(317)
ABI>1.4
ABI<1
1.95
[1.0–3.43]
1.77
[1.31–2.40]
White 38.8%
Chinese 12.7%
African-American 25.6%
Hispanic 23.1%
Consistent findings across Hispanics, Chinese, Whites, Blacks. Adds predictive value to FRS

CVD cardiovascular death, CV cardiovascular